CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial Circadian-Regulated Cell Death in Cardiovascular Diseases 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Mechanisms of Vascular Aging, A Geroscience Perspective JACC Focus Seminar Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses

Original Research(2014) 141 (23): 4500–4512.

JOURNAL:Development. Article Link

The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis

HI Chen , B Sharma, K Red-Horse et al. Keywords: coronary vessel development; endothelium; sinus venosus

Full Text PDF